News
BAX
19.79
+5.77%
1.08
Baxter Overhaul Shifts To Decentralized Model As Recovery Timelines Extend
Simply Wall St · 7h ago
Baxter International Inc. Stock Climbs 5.8%, Outperforms Peers
Dow Jones · 1d ago
Baxter International Inc. stock outperforms competitors on strong trading day
MarketWatch · 1d ago
Looking Into Baxter International Inc's Recent Short Interest
Benzinga · 1d ago
Analysts Offer Insights on Healthcare Companies: Baxter International (BAX) and Ultragenyx Pharmaceutical (RARE)
TipRanks · 1d ago
Baxter International Price Target Cut to $25.00/Share From $30.00 by Barclays
Dow Jones · 1d ago
Baxter International Is Maintained at Overweight by Barclays
Dow Jones · 1d ago
Barclays Maintains Overweight on Baxter Intl, Lowers Price Target to $25
Benzinga · 1d ago
Baxter price target lowered to $20 from $22 at Deutsche Bank
TipRanks · 1d ago
Baxter price target lowered to $25 from $30 at Barclays
TipRanks · 1d ago
Baxter International Earnings Call: Growth Meets Margin Squeeze
TipRanks · 2d ago
Baxter International (BAX) Returns To Quarterly Loss And Tests Earnings Recovery Narrative
Simply Wall St · 2d ago
Stocks Plunge on Tech Weakness and AI Fears
NASDAQ · 2d ago
Baxter International Inc. Stock Slides 16.0%, Underperforms Peers
Dow Jones · 2d ago
Baxter International Inc. stock underperforms Thursday when compared to competitors
MarketWatch · 2d ago
Baxter International: Debt, Margin Pressure, Dreadful FY26 Guidance (Downgrade)
Seeking Alpha · 2d ago
Baxter price target lowered to $19 from $21 at Jefferies
TipRanks · 2d ago
Baxter price target lowered to $20 from $22 at Stifel
TipRanks · 2d ago
Baxter Intl Q4 Earnings Summary & Key Takeaways
Benzinga · 2d ago
Why Baxter International Stock Was Tumbling Today
The Motley Fool · 2d ago
More
Webull provides a variety of real-time BAX stock news. You can receive the latest news about Baxter Intl Inc through multiple platforms. This information may help you make smarter investment decisions.
About BAX
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.